摘要
目的:了解某院调节血脂药的使用情况,为促进临床合理用药提供参考。方法:收集2010—2012年某院临床调节血脂药的用量及销售金额,计算其年增长率;以世界卫生组织推荐的限定日剂量(DDD)为基础计算该类药的用药频度(DDDs)、限定日费用(DDC),并进行统计、分析。结果:2010—2012年该院调节血脂药用量及销售金额逐年上升,他汀类药占主导地位,其中阿托伐他汀年均增幅最大。结论:2010—2012年该院调节血脂药的应用呈递增趋势,他汀类是临床调节血脂药的首选,符合我国高脂血症发病的增长趋势。
OBJECTIVE : To investigate the utilization of lipid-regulating drugs in a hospital for clinical reference of promoting rational use of drugs. METHODS: The lipid-regulating drugs used in a hospital during 2010-2012 period were analyzed statistically with regard to consumption amount, consumption sum, annual incremental rate, DDDs, defined daily dose costs (DDC) using DDD method recommended by WHO. RESULTS: The consumption amount, consumption sum of lipid-regulating drugs increased year by year, with statins showing predominant position and atorvastatin showing the greatest increase. CONCLUSION: The utilization of lipid-regulating drugs in this hospital during 2010-2012 period showed an upward trend, and statins was the first choice of lipid-regulating drugs clinically, which was in conformity with the increasing trend of the morbidity of hypedipidemia.
出处
《中国医院用药评价与分析》
2013年第6期519-521,共3页
Evaluation and Analysis of Drug-use in Hospitals of China